New Prescription Drug Reporting Requirement

As previously reported in December 2021, Section 204 of the Consolidated Appropriations Act, 2021 (“CAA”) requires plan sponsors of group health plans to submit information annually about prescription drugs and health care spending to Centers for Medicare and Medicaid Services (“CMS”) on behalf of the departments of Health and Human Services (“HHS”), Labor (“DOL”), and the Treasury (collectively, the “Departments”). The first deadline is December 27, 2022. CMS recently updated guidance related to this reporting requirement that provides some helpful clarification. Employers with fully insured or self-funded (includes level funded) group health plans, including grandfathered plans, church plans subject to the Internal Revenue Code, and governmental plans. The term “group… Read More

Continue Reading

2017 Employer Reporting Requirements

2017 Employer Reporting Requirements The below document outlines sections 6055 & 6066, the “B” and “C” forms, and the employer reporting obligations to both employees and the IRS. Download 2017_Employer_Reporting_Requirements   Click here to watch a brainshark video that explains the forms and reporting requirements.  

Continue Reading